tm
Seeing Is Believing
tm
Seeing Is Believing
Healthcare - Sector
CALT is currently covered by 4 analysts with an average price target of $42.49. This is a potential upside of $2.49 (6.23%) from yesterday's end of day stock price of $40.
Calliditas Therapeutics's activity chart (see below) currently has 7 price targets and 18 ratings on display. The stock rating distribution of CALT is 84.62% BUY and 15.38% HOLD.
Analysts average stock forecasts to be materialized ratio is 55.56% with an average time for these price targets to be met of 68 days.
Highest price target for CALT is $39, Lowest price target is $39, average price target is $42.49.
Most recent stock forecast was given by YIGAL NOCHOMOVITZ from CITI on 31-May-2024. First documented stock forecast 01-Jul-2020.
Currently out of the existing stock ratings of CALT, 11 are a BUY (84.62%), 2 are a HOLD (15.38%).
Analyst name
Rating
Current price target
Potential Upside
Previous price target
Date
Price targets met ratio
Average potential upside
Average Time (Days) For PT To Be Met
Performance score
Buy
$39
$-1 (-2.50%)
$74
5 months 22 days ago
(31-May-2024)
2/6 (33.33%)
$-0.99 (-2.48%)
82
Hold
$18
$-22 (-55.00%)
$18
1 years 3 months 4 days ago
(18-Aug-2023)
2/2 (100%)
$1.6 (9.76%)
21
Buy
$42
$26.51 (171.14%)
$38
3 years 9 months 5 days ago
(18-Feb-2021)
1/3 (33.33%)
$6.85 (23.74%)
101
What is CALT (Calliditas Therapeutics) average time for price targets to be met?
Which analyst has the current highest performing score on CALT (Calliditas Therapeutics) with a proven track record?
Which analyst has the current lower performing score on CALT (Calliditas Therapeutics) with a proven track record?
Which analyst has the most public recommendations on CALT (Calliditas Therapeutics)?
Which analyst is the currently most bullish on CALT (Calliditas Therapeutics)?
Which analyst is the currently most reserved on CALT (Calliditas Therapeutics)?
